Katren, Roszdravnadzor and Give Life Charity Fund Held Joint Webinar on Pain Treatment and Modern Demands for Drug Release
The webinar was attended by the heads of regional administration offices of Roszdravnadzor and representatives of medical treatment and preventive care institutions from across the country. Altogether, there were 1,642 participants registered.
On February 28, the Federal Service for Surveillance in Healthcare (Roszdravnadzor) and the Give Life Charity Fund both held a joint webinar on the website katrenstyle.ru. This event was dedicated to the important and relevant topic of pain therapy and narcotic drug availability. The webinar consisted of two parts. Firstly, hematologist Alexei Pshonkin, Director of the Palliative Care Department of the Give Life Charity Fund, highlighted the issues of palliative care in Russia, the physiology of pain in children, and the types of analgesic drugs used in different occasions. Then the Head of the Division of Licensing and Enforcement of Compliance with Mandatory Requirements of Roszdravnadzor, Irina Krupnova, covered the problems related to the provision of narcotic drugs to patients with pain syndrome in Russia.
The webinar was attended by more than 1,200 employees of medical treatment and preventive care institutions, about 200 pharmacists, and approximately 70 employees of Roszdravnadzor. Irina Krupnova noted that she was pleased with the cooperation between Roszdravnadzor and the Katren Style Magazine, and intended to continue it in the future. Joint webinars with the Katren Style Magazine were included in the Prevention Activities Programme, aimed at the prevention of violations of mandatory requirements governing the turnover of Roszdravnadzor medicines.
You can listen to the webinar by clicking the link
We also recommend the following additional webinar materials:
The Katren Style online magazine for doctors and pharmacists, which was created and is owned by the national distributor of pharmaceutical products, Katren JSC, continues its cooperation with Roszdravnadzor and other state agencies regulating the pharmaceutical industry. The webinar is open to all listeners who have registered on the website.